Doxorubicin Hydrochloride → Doxorubicin
Reaction equation
[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@@H:9]2[C:14]3=[C:15]([OH:32])[C:16]4[C:28](=[O:29])[C:27]5[C:22](=[CH:23][CH:24]=[CH:25][C:26]=5[O:30][CH3:31])[C:20](=[O:21])[C:17]=4[C:18]([OH:19])=[C:13]3[CH2:12][C@@:11]([OH:37])([C:33]([CH2:35][OH:36])=[O:34])[CH2:10]2)[CH2:5][C@H:4]([NH2:38])[C@@H:3]1[OH:39].Cl>ClCCl>[CH3:1][C@@H:2]1[O:7][C@@H:6]([O:8][C@@H:9]2[C:14]3=[C:15]([OH:32])[C:16]4[C:28](=[O:29])[C:27]5[C:22](=[CH:23][CH:24]=[CH:25][C:26]=5[O:30][CH3:31])[C:20](=[O:21])[C:17]=4[C:18]([OH:19])=[C:13]3[CH2:12][C@@:11]([OH:37])([C:33]([CH2:35][OH:36])=[O:34])[CH2:10]2)[CH2:5][C@H:4]([NH2:38])[C@@H:3]1[OH:39]Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Procedure
The therapeutic solution is prepared by dissolving Doxorubicin hydrochloride, or DOXO, in dichloromethane. The concentration of DOXO in the therapeutic solution is about 1,000 μg/mL.
Workup
- customThe therapeutic solution is prepared
Sources & evidence
- ORD record
- ord-b9de42f86166422aa1a8c29864eb0a4a
- Source dataset
- uspto-grants-2012_10
- Patent number
- US08297959B2
Reaction notes
Loading…